Procter & Gamble Health Ltd banner

Procter & Gamble Health Ltd
NSE:PGHL

Watchlist Manager
Procter & Gamble Health Ltd Logo
Procter & Gamble Health Ltd
NSE:PGHL
Watchlist
Price: 5 138.7 INR -1.29% Market Closed
Market Cap: ₹85.3B

Procter & Gamble Health Ltd
Depreciation & Amortization

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Procter & Gamble Health Ltd
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Procter & Gamble Health Ltd
NSE:PGHL
Depreciation & Amortization
-₹227.9m
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
0%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Depreciation & Amortization
-₹19.6B
CAGR 3-Years
-17%
CAGR 5-Years
-10%
CAGR 10-Years
-11%
Cipla Ltd
NSE:CIPLA
Depreciation & Amortization
-₹11.4B
CAGR 3-Years
-1%
CAGR 5-Years
0%
CAGR 10-Years
-6%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Depreciation & Amortization
-₹28.3B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
-9%
Lupin Ltd
NSE:LUPIN
Depreciation & Amortization
-₹13.2B
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
-11%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Depreciation & Amortization
-₹8.1B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
-13%
No Stocks Found

Procter & Gamble Health Ltd
Glance View

Market Cap
85.3B INR
Industry
Pharmaceuticals

In the vast landscape of healthcare, Procter & Gamble Health Ltd. carves its niche by blending science with daily life, transforming mundane routines into healthier lifestyles. Originally known for its parent company’s deep roots in consumer goods, P&G Health Ltd. has transitioned seamlessly into the pharmaceutical domain, focusing on over-the-counter (OTC) health products and supplements. Its journey is one of leveraging brand trust and an extensive distribution network to ensure that essential health solutions are accessible to consumers around the globe. P&G Health's emphasis on consumer awareness and education propels its growth, as it capitalizes on the modern consumer’s desire for self-care and proactive health management. At the heart of its business model lies a portfolio of products that spans various health categories, encapsulating vitamins, minerals, and supplements that address widespread health needs such as digestive wellness and immunity. The company thrives on innovation and strategic collaboration, utilizing a mix of in-house research alongside partnerships to remain at the forefront of consumer health trends. Revenue streams are buoyed by the strength of its established global market presence and regional expertise, ensuring adaptability across diverse economic landscapes. By catering to both established and emerging markets, Procter & Gamble Health Ltd. sustains its growth momentum, continuously refining its product offerings to meet the dynamic demands of health-conscious consumers.

PGHL Intrinsic Value
4 046.26 INR
Overvaluation 21%
Intrinsic Value
Price ₹5 138.7

See Also

What is Procter & Gamble Health Ltd's Depreciation & Amortization?
Depreciation & Amortization
-227.9m INR

Based on the financial report for Dec 31, 2025, Procter & Gamble Health Ltd's Depreciation & Amortization amounts to -227.9m INR.

What is Procter & Gamble Health Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
0%

Over the last year, the Depreciation & Amortization growth was 10%. The average annual Depreciation & Amortization growth rates for Procter & Gamble Health Ltd have been 8% over the past three years , 4% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett